Javascript must be enabled to continue!
Prevalence and interpretation of Xpert® Ultra trace results among presumptive TB patients
View through CrossRef
BACKGROUND: The “trace call” results on Xpert® Ultra indicates extremely low TB levels and may be difficult to interpret. The prevalence of trace results among presumptive TB patients in high TB-HIV infection settings is unknown, as is the significance of divergent
“trace call” result interpretations.METHODS: Presumptive TB patients attending a public health facility in Lusaka, Zambia, were prospectively enrolled. Participants underwent several TB investigations, including sputum smear microscopy, Ultra testing, and culture. The
diagnostic accuracy of Ultra (culture-based reference) and the number of patients recommended for TB treatment was assessed according to several different interpretation criteria for “trace call” results.RESULTS: Among the 740 participants, 78 (10.5%) were Ultra-positive
and an additional 37 (5.0%) had a “trace call” result. The prevalence of trace results did not differ according to HIV status (5.3% vs. 4.8%) or prior TB status (5.6% vs. 4.9%). Differing interpretations of trace results had modest effects on Ultra’s sensitivity (range 79.3–82.6%)
and specificity (range 94.3–99.2%), but increased the number of patients recommended for treatment by up to 44.9%.CONCLUSIONS: Ultra trace results were common in this setting. The interpretation of trace results may substantially impact TB case yield.
International Union Against Tuberculosis and Lung Disease
Title: Prevalence and interpretation of Xpert® Ultra trace results among presumptive TB patients
Description:
BACKGROUND: The “trace call” results on Xpert® Ultra indicates extremely low TB levels and may be difficult to interpret.
The prevalence of trace results among presumptive TB patients in high TB-HIV infection settings is unknown, as is the significance of divergent
“trace call” result interpretations.
METHODS: Presumptive TB patients attending a public health facility in Lusaka, Zambia, were prospectively enrolled.
Participants underwent several TB investigations, including sputum smear microscopy, Ultra testing, and culture.
The
diagnostic accuracy of Ultra (culture-based reference) and the number of patients recommended for TB treatment was assessed according to several different interpretation criteria for “trace call” results.
RESULTS: Among the 740 participants, 78 (10.
5%) were Ultra-positive
and an additional 37 (5.
0%) had a “trace call” result.
The prevalence of trace results did not differ according to HIV status (5.
3% vs.
4.
8%) or prior TB status (5.
6% vs.
4.
9%).
Differing interpretations of trace results had modest effects on Ultra’s sensitivity (range 79.
3–82.
6%)
and specificity (range 94.
3–99.
2%), but increased the number of patients recommended for treatment by up to 44.
9%.
CONCLUSIONS: Ultra trace results were common in this setting.
The interpretation of trace results may substantially impact TB case yield.
Related Results
The Value of Lateral Flow Urine Lipoarabinomannan Assay and Empirical Treatment in the Xpert MTB/RIF Ultra Era: a Prospective Cohort Study
The Value of Lateral Flow Urine Lipoarabinomannan Assay and Empirical Treatment in the Xpert MTB/RIF Ultra Era: a Prospective Cohort Study
Abstract
Introduction: The value of Lateral Flow urine Lipoarabinomannan (LF-LAM) assay and the role of empiric tuberculosis (TB) treatment in the era of the highly sensiti...
The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study
The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study
AbstractThe value of Lateral Flow urine Lipoarabinomannan (LF-LAM) assay and the role of empiric tuberculosis (TB) treatment in the era of the highly sensitive Xpert MTB/RIF Ultra ...
Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South Africa
Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South Africa
Abstract
Background
The World Health Organization–approved Xpert MTB/XDR test detects Mycobacterium tuberculosis and resistance ...
Oral Swab Xpert MTB/RIF Ultra for Tuberculosis Diagnosis in Ethiopian Prisons
Oral Swab Xpert MTB/RIF Ultra for Tuberculosis Diagnosis in Ethiopian Prisons
ABSTRACT
As asymptomatic (subclinical) tuberculosis (TB) is increasingly recognized, there is a need for sputum-free diagnostic approaches applicable to both sympto...
The role of chest radiography in the diagnosis of bacteriologically confirmed pulmonary tuberculosis in hospitalised Xpert MTB/RIF-negative patients
The role of chest radiography in the diagnosis of bacteriologically confirmed pulmonary tuberculosis in hospitalised Xpert MTB/RIF-negative patients
The role of chest radiography to diagnose active tuberculosis in symptomatic patients who have a negative Xpert MTB/RIF (Xpert) test result is unclear. This study aimed to assess t...
Clinical spectrum of admitted patients undergoing Xpert MTB/RIF® testing for tuberculosis evaluation at a tertiary care hospital
Clinical spectrum of admitted patients undergoing Xpert MTB/RIF® testing for tuberculosis evaluation at a tertiary care hospital
Abstract
Background:
The introduction of Xpert MTB/RIF® has revolutionised the diagnosis of tuberculosis (TB) by reducing time to the identificat...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Rapid detection of non-rifampicin drug resistant tuberculosis using Xpert MTB/XDR testing: Findings from a multisite drug-resistant tuberculosis case detection surge in Zambia
Rapid detection of non-rifampicin drug resistant tuberculosis using Xpert MTB/XDR testing: Findings from a multisite drug-resistant tuberculosis case detection surge in Zambia
Abstract
Background
Zambia continues to face a high burden of tuberculosis with rising drug resistance, yet diagnosis of non-ri...

